MedPath
NMPA Approval

Crovalimab Injection

国药准字SJ20240007

February 6, 2024

Drug Information

可伐利单抗注射液

派圣凯

注射剂

340mg(2ml)/瓶

生物制品

February 6, 2024

February 5, 2029

Company Information

Applicant Company

Grenzacherstrasse 124, 4058 Basel, Switzerland

Manufacturing Company

GENENTECH INC

1 DNA Way, South San Francisco, California (CA) 94080, United States (USA)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

可伐利单抗注射液 - NMPA 批准文号 | MedPath